Results 161 to 170 of about 145,378 (214)

Lithium as a Potential Neuroprotective Strategy in Glaucoma: Mechanisms and Therapeutic Perspectives. [PDF]

Biomolecules
Alessio M, Giulia N, Annagrazia A, Francesco A, Raffaele M, Massimo C, Giacinto B, Carlo N, Romano E, Rossella R.   +9 more
europepmc   +1 more source

Deep Learning-Assisted Differentiation of Four Peripheral Neuropathies Using Corneal Confocal Microscopy. [PDF]

Ann Clin Transl Neurol
Rabah CB, Petropoulos IN, Stettner M, Ferdousi M, Alam U, Efron N, Serag A, Malik RA.   +7 more
europepmc   +1 more source

Amyloidosis & Advanced Heart Failure: When to Consider Cardiac Transplantation and What are the Results? [PDF]

Curr Heart Fail Rep
Hamilton S, Patolia H, Hanna M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hereditary and acquired amyloid neuropathies

Journal of Neurology, 2001
Amyloid neuropathies occur in a context of hereditary (FAP) or acquired amyloidosis. They present usually as severe and progressive polyneuropathy and carry a poor prognosis. Most FAP are associated with endoneurial deposits of variant transthyretin (TTR) with substitution of one aminoacid and are secondary to a point mutation of the TTR gene. Portugal
David Adams
exaly   +3 more sources

Acquired and Genetic Amyloid Neuropathies

Neurologic Clinics
Amyloidosis is a potentially treatable cause of polyneuropathy with various distinct etiologies, including amyloid light chain (AL), transthyretin variant (ATTRv), wild-type transthyretin amyloidosis (wrATTR), gelsolin, and apolipoprotein A1 (ApoA-I). Among these, AL and transthyretin amyloidosis are the most common, while AGel and ApoA-I amyloidosis ...
Mamatha Pasnoor, Richard J Barohn, Mazen Dimachkie   +2 more
exaly   +3 more sources

Amyloid neuropathies

Vestnik Nevrologii, Psihiatrii I Nejrohirurgii
Amyloid neuropathy is a rare condition characterized by the pathological deposition of amyloid fibrils within the peripheral and autonomic nervous systems, leading to progressive sensorimotor and autonomic dysfunction. More than 15 types of systemic amyloidosis have been identified, each associated with a specific precursor protein involved in the ...
I. M. Efimov, P. V. Anisimova, A. A. Shibzukhov, M. B. Tambieva, Yu. V. Skovorodka, N. A. Chernyshova, K. A. Artemova, M. N. Nazarova   +7 more
exaly   +2 more sources

Current and future treatment of amyloid neuropathies

Expert Review of Neurotherapeutics, 2014
Amyloid neuropathies of acquired or genetic origin are disabling and life-threatening, until recently there were few treatment options available. Poor prognosis is related to progressive neuropathy and associated, although often underdiagnosed, cardiac involvement in specific transthyretin (TTR) gene mutations.
Vincent Algalarrondo, Marie Théaudin, Antoine Rousseau   +2 more
exaly   +3 more sources

Neuropathies, Amyloid

2003
Robert W Shields
exaly   +2 more sources